Who owns PACIRA BIOSCIENCES INC?
- CUSIP Number: 695127aj9
Tip: Access positions for across all investors
Analyze quarterly positions in Pacira Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pacira Biosciences stock
Who bought or sold PACIRA BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 109M | $110M | 2% | Dec 2025 |
|
| Context Capital Management | 69M | $69M | 90876% | Dec 2025 |
|
| Lazard Asset Management | 18M | $181k | 101% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 13M | $13M | 0% | Dec 2025 |
|
| Silverback Asset Management | 12M | $12M | -28% | Sep 2025 |
|
| Absolute Investment Advisers | 9.0M | $9.1M | 12% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 8.0M | $8.0M | -20% | Dec 2025 |
|
| Leucadia National Corporation | 7.1M | $7.2M | 19% | Dec 2025 |
|
| Calamos Advisors | 6.5M | $6.6M | 0% | Dec 2025 |
|
| D. E. Shaw & Co | 6.0M | $6.1M | 0% | Sep 2025 |
|
| Capstone Investment Advisors | 5.0M | $5.0M | 0% | Dec 2025 |
|
| BlackRock | 3.7M | $3.7M | 28% | Dec 2025 |
|
| FMR | 3.4M | $3.5M | -8% | Sep 2025 |
|
| Wellesley Investment Advisors | 3.4M | $3.4B | 106% | Dec 2025 |
|
| Advent Capital Management | 3.3M | $3.3M | 100% | Dec 2025 |
|
| SSI Investment Management | 2.0M | $2.0M | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.9M | $1.9M | 100% | Sep 2025 |
|
| Cutler Capital Management | 1.5M | $1.5M | 0% | Dec 2025 |
|
| CSS | 75k | $76k | 100% | Dec 2025 |
|
| Virtus ETF Advisers | 44k | $44k | 0% | Dec 2025 |
|
| Insigneo Advisory Services | 12k | $12k | 100% | Dec 2025 |
|
Who sold out of Pacira Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Gabelli Funds | Sep 2025 | 1.3M | $1.3M |
| Toronto-Dominion Bank | Jun 2025 | 1.0M | $974k |
| Penn Mutual Asset Management | Sep 2025 | 1.0M | $1.0M |